Response to: ‘Let's stop fooling ourselves. In RA, only ACR/EULAR criteria define remission and equate with absence of disease!’ by Boers

P Emery; C O Bingham; G R Burmester; V P Bykerk; D E Furst; X Mariette; D van der Heijde; R van Vollenhoven; C Arendt; I Mountian; O Purcaru; D Tatla; B VanLunen; M E Weinblatt

doi:10.1136/annrheumdis-2016-210083

Article info

Electronic pages

Correspondence response

Response to: ‘Let's stop fooling ourselves. In RA, only ACR/EULAR criteria define remission and equate with absence of disease!’ by Boers

Free

Authors

P Emery Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK PubMed articles Google scholar articles
C O Bingham John Hopkins University, Baltimore, USA PubMed articles Google scholar articles
G R Burmester Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK PubMed articles Google scholar articles
V P Bykerk Weill Cornell Medical College, Division of Rheumatology, Hospital for Special Surgery, New York, USA PubMed articles Google scholar articles
D E Furst Division of Rheumatology, David Geffen School of Medicine at UCLA, Los Angeles, USA PubMed articles Google scholar articles
X Mariette Université Paris-Sud, Hôpitaux Universitaires Paris-Sud, AP-HP, INSERM U1184, Le Kremlin Bicêtre, France PubMed articles Google scholar articles
D van der Heijde Leiden University Medical Centre, Leiden, The Netherlands PubMed articles Google scholar articles
R van Vollenhoven Unit for Clinical Therapy Research, Inflammatory Disease, Karolinska Institute, Stockholm, Sweden PubMed articles Google scholar articles
C Arendt UCB Pharma, Brussels, Belgium PubMed articles Google scholar articles
I Mountian UCB Pharma, Brussels, Belgium PubMed articles Google scholar articles
O Purcaru UCB Pharma, Brussels, Belgium PubMed articles Google scholar articles
D Tatla UCB Pharma, Raleigh, USA PubMed articles Google scholar articles
B VanLunen UCB Pharma, Raleigh, USA PubMed articles Google scholar articles
M E Weinblatt Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, USA PubMed articles Google scholar articles

Correspondence to Professor Paul Emery, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Chapeltown Road, Leeds LS7 4SA, UK; p.emery{at}leeds.ac.uk

View Full Text

Citation

Emery P, Bingham CO, Burmester GR, et al

Response to: ‘Let's stop fooling ourselves. In RA, only ACR/EULAR criteria define remission and equate with absence of disease!’ by Boers

Annals of the Rheumatic Diseases 2016;75:e69.

Publication history

Received July 2, 2016
Accepted July 3, 2016
First published August 12, 2016.

Online issue publication

September 09, 2016

Article Versions

Previous version (9 September 2016).
You are viewing the most recent version of this article.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Article Versions

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password